Algert Global LLC

SEC CIK: 0001275218
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 18; Since Q1 2021

Holdings of APLS by Algert Global LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−109,733−100.0%	Sold out	Holders
Q4 2025	109,733	$2.76M	<0.1%	00.0%	Unchanged	Holders
Q3 2025	109,733	$2.48M	<0.1%	−44,380−28.8%	Reduced	Holders
Q2 2025	154,113	$2.67M	0.1%	−184,500−54.5%	Reduced	Holders
Q1 2025	338,613	$7.41M	0.2%	+56,328+20.0%	Added	Holders
Q4 2024	282,285	$9.01M	0.2%	+199,874+242.5%	Added	Holders
Q3 2024	82,411	$2.38M	0.1%	−41,217−33.3%	Reduced	Holders
Q2 2024	123,628	$4.74M	0.2%	+71,650+137.8%	Added	Holders
Q1 2024	51,978	$3.06M	0.1%	+11,049+27.0%	Added	Holders
Q4 2023	40,929	$2.45M	0.1%	−19,375−32.1%	Reduced	Holders
Q3 2023	60,304	$2.29M	0.1%	+32,505+116.9%	Added	Holders
Q2 2023	27,799	$2.53M	0.1%	−14,900−34.9%	Reduced	Holders
Q1 2023	42,699	$2.82M	0.1%	+9,468+28.5%	Added	Holders
Q4 2022	33,231	$1.72M	0.1%	00.0%	Unchanged	Holders
Q3 2022	33,231	$2.27M	0.1%	+1,847+5.9%	Added	Holders
Q2 2022	31,384	$1.42M	0.1%	+11,121+54.9%	Added	Holders
Q1 2022	20,263	$1.03M	0.1%	+12,896+175.1%	Added	Holders
Q4 2021	7,367	$348.0K	<0.1%	+7,367	New	Holders
Q2 2021	0	$0	0.0%	−8,979−100.0%	Sold out	Holders
Q1 2021	8,979	$385.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.